Apremilast Alleviates Severe Psoriasis in Some Children, Data Show Apremilast Alleviates Severe Psoriasis in Some Children, Data Show
Proportionally more children treated with apremilast than with placebo achieved a Physician ' s Global Assessment response at week 16, with no new safety concerns highlighted.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 19, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

Hope Shines Bright for Hidradenitis Suppurativa Treatments Hope Shines Bright for Hidradenitis Suppurativa Treatments
Secukinumab and the investigational drug brepocitinib were shown to alleviate the effects of the chronic and painful skin condition in separate, unrelated trials.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 16, 2022 Category: Dermatology Tags: Dermatology News Source Type: news

Litifilimab Meets Primary Endpoint in Phase 2 Lupus Trial Litifilimab Meets Primary Endpoint in Phase 2 Lupus Trial
Treatment group saw greater reduction in number of tender and swollen joints.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 13, 2022 Category: Dermatology Tags: Rheumatology News Source Type: news

Novel Study Offers Clues to Sex Bias in Lupus Incidence Novel Study Offers Clues to Sex Bias in Lupus Incidence
Researchers compared immune cells in cisgender and transgender subjects to investigate the role of sex hormones independently from chromosomes in a study on sex bias in autoimmune disease.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 12, 2022 Category: Dermatology Tags: Rheumatology News Source Type: news

FDA Approves Oral TYK2 Inhibitor for Treating Psoriasis FDA Approves Oral TYK2 Inhibitor for Treating Psoriasis
Deucravacitinib, an oral, selective tyrosine kinase 2 (TYK2) inhibitor, is the first drug in this class to be approved.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - September 12, 2022 Category: Dermatology Tags: Dermatology News Alert Source Type: news